» Articles » PMID: 25028494

Intraoperative Mass Spectrometry of Tumor Metabolites

Overview
Specialty Science
Date 2014 Jul 17
PMID 25028494
Authors
Affiliations
Soon will be listed here.
References
1.
Cairns R, Mak T . Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov. 2013; 3(7):730-41. DOI: 10.1158/2159-8290.CD-13-0083. View

2.
Liu X, Ide J, Norton I, Marchionni M, Ebling M, Wang L . Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep. 2013; 3:2859. PMC: 3790202. DOI: 10.1038/srep02859. View

3.
Mrugala M . Advances and challenges in the treatment of glioblastoma: a clinician's perspective. Discov Med. 2013; 15(83):221-30. View

4.
Tran D, Jensen R . Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int. 2013; 4(Suppl 3):S129-35. PMC: 3654777. DOI: 10.4103/2152-7806.110661. View

5.
Sanai N, Berger M . Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008; 62(4):753-64. DOI: 10.1227/01.neu.0000318159.21731.cf. View